Neta Shlezinger
Krill Prize 2024
The Hebrew University
Neta Shlezinger
Affiliation at the time of the award:
The Hebrew University of Jerusalem
The Robert H. Smith Faculty of Agriculture, Food and Environment
Koret School of Veterinary Medicine
Award Citation:
“for significant contributions in the study of pathogenic fungi, understanding the mechanisms that allow them to overcome the body’s immune system, and developing innovative methods to defend against them”
More than 1.6 million people die each year due to fungal infections. Every year, increasingly deadly fungal diseases are discovered, yet there remains a paucity of knowledge on how to combat them. Worldwide, about five million species of fungi are known, several hundred of which are pathogenic to humans. Some of these fungi are drug-resistant and are classified by the Centers for Disease Control (CDC) as a ‘serious global health threat.’ Fungi constitute a distinct kingdom in nature, alongside animals and plants. Despite their significance, some properties of fungi remain unknown, complicating the development of drugs to treat the infections they cause.
The increase in fungal diseases is linked to several factors: the climate crisis, which causes more species of fungi to adapt to high temperatures and survive in the human body; Smart fungi developed resistance against most types of drugs; and the use of new drugs that weaken the immune system, making it easier for fungi to thrive in the human body. Fungi have learned to thrive in environments where we are most vulnerable, such as hospitals, especially in intensive care units. During the COVID-19 pandemic, about 30 percent of those hospitalized in intensive care units developed fatal fungal infections, and approximately sixty percent of them died after treatment.
Dr. Neta Shlezinger employs a multidisciplinary approach to understand the mechanisms enabling fungi to evade the immune system, comprehend the host body’s immune response against fungal pathogens, and develop innovative methods to combat fungi. One method she has demonstrated is inducing apoptosis – “programmed cell death” in fungi, essentially causing them to self-destruct. Another approach involves harnessing mycoviruses—viruses that infect fungi—to fight against them. The outcomes of her research are expected to lead to the development of novel antifungal drugs and diagnostic tools relevant to public health, agriculture, and wildlife.
Dr. Neta Shlezinger completed her bachelor’s, master’s, and doctoral degrees at the Hebrew University of Jerusalem, followed by a postdoctoral fellowship at the Memorial Sloan Kettering Cancer Research Center. She currently serves as a senior lecturer at the School of Veterinary Medicine at the Hebrew University of Jerusalem.